Mankind Pharma Ltd (MANKIND)

is exhibiting high volatility following a sharp rejection from its recent highs. After a strong rally toward 2,320, the stock saw a "Head and Shoulders" type rejection. The last few trading sessions have been aggressively bearish, characterized by large red candles. It is currently testing a horizontal support line near 2,100 – 2,120. This is a "make or break" zone. The sharp decline suggests strong selling pressure. If the 2,087 support level fails, the stock could slide further toward the 2,000 psychological level. It needs a period of consolidation (sideways movement) before any fresh "Buy" signal can be considered.